Y.-M. Jhou et al. / Polyhedron 100 (2015) 28–35
33
6.99 (t, J = 9.0 Hz, 2H, Ar H), 7.28–7.49 (m, 9H, Ar H and imi H),
10.39 (s, 1H, NCHN). 13C{1H} NMR (CDCl3) d, ppm: 37.9 (CH3),
51.2 (CH2), 52.3 (CH2), 116.3 (d, J = 21.9 Hz, Ar C), 121.0, 123.9,
127.5, 129.0, 129.2 (d, J = 3.0 Hz, quaternary C), 130.4, 131.0 (d,
J = 8.3 Hz, Ar C), 138.3 (quaternary C), 140.8 (NCHN), 163.0 (d,
J = 249.1 Hz, CF), 164.2 (C@O).
4. Experimental
4.1. Materials and methods
All manipulations were performed under a dry nitrogen atmo-
sphere using standard Schlenk techniques. Solvents were dried
with standard procedures. Starting chemicals were purchased from
commercial sources and used as received. Compounds 1e [6], A
[12], 3e [6] and 4b [5] were prepared according to the literature
procedures. 1H, 13C{1H} and 19F{1H} NMR spectra were recorded
at 300.13, 75.48 and 282.23 MHz, respectively. Elemental analyses
were performed on a Thermo Flash 2000 CHN-O elemental ana-
lyzer. ESI-MS was carried out on a Finnigan/Thermo Quest MAT
95XL mass spectrometer.
4.1.5. Synthesis of 2e
A mixture of 1-(2,4,6-trimethylphenyl)-1H-imidazole (1.27 g,
6.83 mmol) and 2-chloro-N-phenylacetamide (1.16 g, 6.83 mmol)
in DMF (10 mL) was heated at 110 °C for 2 d. The solvent was then
removed completely under vacuum. THF was added to the residue,
giving a white solid which was filtered under nitrogen, washed
with THF and dried under vacuum. Yield: 1.46 g, 61%, mp: 212.5–
214.5 °C (dec). Anal. Calc. for C20H22ClN3O: C, 67.51; H, 6.24; N,
11.80. Found: C, 67.58; H, 6.77; N, 11.73%. 1H NMR (CDCl3) d,
ppm: 2.04 (s, 6H, o-Me), 2.32 (s, 3H, p-Me), 5.88 (s, 2H, CH2C@O),
6.97 (s, 2H, Mes H), 7.01–7.07 (m, 2H, Ar H, imi H), 7.20 (t,
J = 6.0 Hz, 2H, Ar H), 7.72 (d, JHH = 9.0 Hz, 2H, Ar H), 7.79 (s, 1H,
imi H), 9.74 (s, 1H, NCHN), 11.5 (s, 1H, NH). 13C{1H} NMR (CDCl3)
d, ppm: 17.5 (CH3), 21.1 (CH3), 52.7 (CH2), 120.1, 122.3, 124.3 (qua-
ternary C), 124.5 (quaternary C), 128.7, 129.8, 130.6 (quaternary C),
134.3, 138.0, 138.3 (quaternary C), 141.3 (NCHN), 163.0 (C@O).
4.1.1. Synthesis of 1a
A mixture of 1-methylimidazole (0.89 g, 10.8 mmol) and 2-
chloro-N-methyl-N-phenylacetamide (1.99 g, 10.8 mmol) in THF
(30 mL) was heated at 80 °C for 2 d. The white solid formed was fil-
tered under nitrogen, washed with THF and dried under vacuum.
Yield: 2.13 g, 73%, mp: 240.3–242.8 °C (dec). Anal. Calc. for
C
13H16ClN3O: C, 58.75; H, 6.06; N, 15.81. Found: C, 59.22; H,
6.06; N, 15.87%. 1H NMR (CDCl3) d, ppm: 3.26 (s, 3H, PhNCH3),
3.97 (s, 3H, NCH3), 5.12 (s, 2H, CH2), 7.28–7.48 (m, 7H, imi H and
Ph H), 10.37 (s, 1H, NCHN). 13C{1H} NMR (DMSO-d6) d, ppm: 36.2
(CH3), 37.8 (CH3), 50.9 (CH2), 123.1, 124.4, 127.9, 128.9 (quaternary
C), 130.4, 138.2, 141.7 (NCHN), 165.1 (C@O).
4.1.6. Synthesis of 3a
To a 50 mL Schlenk flask containing A (0.15 g, 0.41 mmol), 1a
(0.22 g, 0.82 mmol) and potassium carbonate (0.12 g, 0.82 mmol)
was added dry DMF (10 mL). The mixture was allowed to stir for
5 h at ambient temperature. The solvent was completely removed
under vacuum. The residue was dissolved in dichloromethane. The
organic layer was then washed twice with water. After drying with
anhydrous magnesium sulfate, the solvent was completely
removed under vacuum. The residue was washed with diethyl
ether. The pale yellow solid was then filtered on a frit and dried
under vacuum. Yield: 0.24 g, 89%, mp: 163.5–165.6 °C (dec). Anal.
Calc. for C30H32N6O5Pd: C, 56.34; H, 4.86; N, 12.67. Found: C,
56.12; H, 4.89; N, 12.43%. 1H NMR (CDCl3) d, ppm: 3.25 (s, 8H,
CONCH3, CCH@CHC), 3.37 (s, 6H, NCH3), 4.69 (AB quartet,
4.1.2. Synthesis of 1b
The compound was prepared following a similar procedure as
for 1a. 1-Benzyl-1H-imidazole (1.84 g, 11.6 mmol) and 2-chloro-
N-methyl-N-phenylacetamide (2.14 g, 11.6 mmol) were used. A
white solid was obtained. Yield: 2.22 g, 56%, mp: 168.3–169.8 °C
(dec). Anal. Calc. for C19H20ClN3O: C, 66.75; H, 5.89; N, 12.29.
Found: C, 66.57; H, 6.02; N, 12.38%. 1H NMR (CDCl3) d, ppm: 3.25
(s, 3H, NCH3), 5.10 (s, 2H, CH2C@O), 5.42 (s, 2H, PhCH2), 7.10 (s,
1H, imi H), 7.27 (s, 1H, imi H), 7.31–7.50 (m, 10H, Ph H), 10.68 (s,
1H, NCHN). 13C{1H} NMR (CDCl3) d, ppm: 37.7 (CH3), 51.1 (CH2),
52.9 (CH2), 121.1, 124.2, 127.5, 128.6, 128.8 (quaternary C),
129.1, 129.2, 130.3, 133.3, 138.0 (quaternary C), 140.8 (NCHN),
164.3 (C@O).
J = 18.0 Hz,
Dm = 65.5 Hz, 4H, NCH2), 6.77 (s, 2H, imi H), 6.88 (s,
3
2H, imi H), 7.27 (d, JHH = 6.0 Hz, 4H, o-Ph H), 7.38–7.48 (m, 6H,
Ar-H). 13C{1H} NMR (DMSO-d6) d, ppm: 37.3 (CH3), 37.5 (CH3),
37.7 (CCH@CHC), 52.3 (CH2), 122.5, 123.3, 127.7, 128.5, 129.0,
129.4, 130.3, 136.6, 142.5 (quaternary C), 166.6 (CH2C@O), 173.6
(CHCO@O), 187.3 (NCN).
4.1.3. Synthesis of 1c
The compound was prepared following a similar procedure as
for 1a. 1-(4-Methoxybenzyl)-1H-imidazole (4.04 g, 21.0 mmol)
and 2-chloro-N-methyl-N-phenylacetamide (3.94 g, 21.0 mmol)
were used. A white solid was obtained. Yield: 4.55 g, 57%, mp:
221.3–225.8 °C (dec). Anal. Calc. for C20H22ClN3O2: C, 64.59; H,
5.96; N, 11.3. Found: C, 64.47; H, 6.03; N, 11.47%. 1H NMR
(CDCl3) d, ppm: 3.26 (s, 3H, NCH3), 3.75 (s, 3H, OCH3), 5.09 (s,
2H, CH2C@O), 5.35 (s, 2H, ArCH2), 6.85 (d, J = 6.0 Hz, 2H, Ar H),
7.07 (s, 1H, imi H), 7.21 (s, 1H, imi H), 7.29–7.51 (m, 7H, Ar H),
10.55 (s, 1H, NCHN). 13C{1H} NMR (CDCl3) d, ppm: 37.8 (CH3),
51.1 (CH2), 52.9 (CH2), 55.3 (OCH3), 114.7, 120.5, 123.7, 124.8,
127.4, 129.0 (quaternary C), 130.4, 130.5, 138.5 (quaternary C),
140.8 (NCHN), 160.3 (quaternary C), 164.1 (C@O).
4.1.7. Synthesis of 3b
The compound was prepared following a similar procedure as
for 3a. Compound A (0.21 g, 0.56 mmol), 1b (0.38 g, 1.13 mmol)
and K2CO3 (0.16 g, 1.13 mmol) were used. A pale yellow solid
was obtained. Yield: 0.26 g, 58%, mp: 166.6–167.5 °C (dec). Anal.
Calc. for C42H40N6O5Pd: C, 61.87; H, 4.94; N, 10.31. Found: C,
62.29; H, 5.40; N, 9.84%. 1H NMR (CDCl3) d, ppm: 3.02 (s, 6H,
NCH3), 3.11 (s, 2H, CCH@CHC), 4.52 (d, J = 18.0 Hz, 2H,
CHaHbC@O), 4.83 (d, J = 18.0 Hz, 2H, CHaHbC@O), 4.95 (s, 4H,
ArCH2), 6.73 (s, 2H, imi H), 6.80–6.82 (m, 4H, Ar H), 6.92 (s, 2H,
imi H), 7.09 (d, J = 9.0 Hz, 4H, Ar H), 7.28–7.35 (m, 12H, Ar H).
13C{1H} NMR (CDCl3) d, ppm: 37.2 (NCH3), 39.0 (CCH@CHC), 52.9
(CH2C@O), 54.1 (PhCH2), 120.8, 123.0, 126.9, 127.1, 127.8, 128.6,
130.3, 136.8 (quaternary C), 141.4 (quaternary C), 166.8
(CH2C@O), 174.4 (CHCO@O), 189.3 (NCN).
4.1.4. Synthesis of 1d
The compound was prepared following a similar procedure as
for 1a. 1-(4-Fluorobenzyl)-1H-imidazole (6.71 g, 38.0 mmol) and
2-chloro-N-methyl-N-phenylacetamide (6.99 g, 38.0 mmol) were
used. A white solid was obtained. Yield: 9.18 g, 67%, mp: 142.3–
144.8 °C (dec). Anal. Calc. for C19H19ClN3OF: C, 63.42; H, 5.32; N,
11.68. Found: C, 63.74; H, 5.51; N, 11.55%. 1H NMR (CDCl3) d,
ppm: 3.23 (s, 3H, CH3), 5.04 (s, 2H, CH2C@O), 5.46 (s, 2H, PhCH2),
4.1.8. Synthesis of 3c
The compound was prepared following a similar procedure as
for 3a. Compound A (0.35 g, 0.94 mmol), 1c (0.70 g, 1.88 mmol)
and K2CO3 (0.26 g, 1.88 mmol) were used. A pale yellow solid
was obtained. Yield: 0.65 g, 80%, mp: 171.2–172.9 °C (dec). Anal.